APA Style

Real‑World Effectiveness of Once‑Weekly Glucagon‑Like Peptide‑1 Receptor Agonists (OW GLP‑1RAs) in Comparison with Dipeptidyl Peptidase‑4 Inhibitors (DPP‑4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE). (). : .

MLA Style

Real‑World Effectiveness of Once‑Weekly Glucagon‑Like Peptide‑1 Receptor Agonists (OW GLP‑1RAs) in Comparison with Dipeptidyl Peptidase‑4 Inhibitors (DPP‑4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE). . : , . PRODUCT LITERATURE.